Calcium-phosphate metabolism parameters and erythrocyte Ca2+ concentration in autosomal dominant polycystic kidney disease patients with normal renal function

Archives of Medical Science

Volumn 9, Issue 5, 2013, Pages 837-842

  Pietrzak Nowacka, Maria ^a   Safranow, Krzysztof ^a   Bober, Joanna ^a   Olszewska, Maria ^a   Birkenfeld, Bozena ^a   Nowosiad, Monika ^a   Ciechanowski, Kazimierz ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Calcium; Inorganic phosphate; Magnesium; Parathormone; Polycystins

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; CREATININE; FURA 2; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; POTASSIUM; SODIUM;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; ELECTROLYTE METABOLISM; ERYTHROCYTE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MALE; METABOLIC PARAMETERS; PHENOTYPE; POTASSIUM BLOOD LEVEL; SODIUM BLOOD LEVEL;

EID: 84873099639     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2012.30834     Document Type: Article

References (27)

1. Dehesa-López E, Pérez-Gutiérrez RA, Valdez-Ortiz R, Morales-Buenrostro LE, Correa-Rotter R. Clinical and laboratorial predictors related to progression to chronic kidney disease in patients with autosomal dominant polycystic kidney disease. Rev Invest Clin 2009; 61: 364-70.
2. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium. Cell 1994; 77: 881-94.
3. Kimberling WJ, Kumar S, Gabow PA, Kenyon JB, Connolly CJ, Somlo S. Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics 1993; 18: 467-72. (Pubitemid 24021060)
4. Joly D, Hummel A, Ruello A, Knebelmann B. Ciliary function of polycystins: a new model for cystogenesis. Nephrol Dial Transplant 2003; 18: 1689-92. (Pubitemid 37098533)
5. Gallagher AR, Germino GG, Somlo S. Molecular advances in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17: 118-30.
6. Hanaoka K, Qian F, Boletta A, et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000; 408: 990-4. (Pubitemid 32101647)
7. Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 2006; 17: 178-87.
8. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, Calvet JP. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 2004; 279: 40419-30. (Pubitemid 39287631)
9. Pontoriero G, Cozzolino M, Locatelli F, Brancaccio D. CKD patients: the dilemma of serum PTH levels. Nephron Clin Pract 2010; 116: c263-8.
10. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994; 343: 824-7. (Pubitemid 24147512)
11. Nair DR, Mehta S, Mikhailidis DP. Assessing renal function - searching for the perfect marker continues! Arch Med Sci 2011; 7: 565-7.
12. Soldati L, Adamo D, Manunta P, et al. Erythrocyte calcium influx is related to severity of ventricular arrhythmias in uraemic patients. Nephrol Dial Transplant 2001; 16: 85-90. (Pubitemid 32051478)
13. Chapman AB, Stepniakowski K, Rahbari-Oskoui F. Hypertension in autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis 2010; 17: 153-63.
14. Resnick LM, Gupta RK, DiFabio B, et al. Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade. J Clin Invest 1994; 94: 1269-76.
15. Greenberg A. Diuretic complications. Am Med Sci 2000; 319: 10-24. (Pubitemid 30367871)
16. Fliser D, Pacini G, Engelleiter R, et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343-7. (Pubitemid 28316896)
17. Messa P, Vallone C, Mioni G, et al. Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients. Kidney Int 1994; 46: 1713-20. (Pubitemid 24370489)
18. Ubara Y, Takaichi K. Ca and Vit D derivatives on stage of renal failure. Clin Calcium 2003; 13: 938-43.
19. Smirnov AV, Volkov MM, Galkina OV, Zhloba AA, Emanuél' VL. Correlations between the levels of vitamin D, parathormone, calcium, blood phosphates in patients with chronic kidney disease not treated with kidney replacement therapy. Ter Arkh 2009; 81: 49-52.
20. Paraskevopoulos A, Agroyannis B, Kopelias L, et al. Changes in erythrocyte calcium and potassium in patients during HD and CAPD. Int J Artif Organs 2000; 23: 750-3. (Pubitemid 32010992)
21. Buemi M, Allegra A, Marino D, et al. Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension. Nephron 1997; 76: 369-70. (Pubitemid 27296553)
22. Lajdova I, Spustova V, Oksa A, Chorvatova A, Chorvat D Jr, Dzurik R. Intracellular calcium homeostasis in patients with early stages of chronic kidney disease: effects of vitamin D3 supplementation. Nephrol Dial Transplant 2009; 24: 3376-81.
23. Soldati L, Adamo D, Zerbi S, et al. Erythrocyte voltage-dependent calcium influx is reduced in hemodialyzed patients. Kidney Int 1999; 56: 190-7. (Pubitemid 29300534)
24. Yamaguchi T, Pelling JC, Ramaswamy NT, et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 2000; 57: 1460-71. (Pubitemid 30207906)
25. Yamaguchi T, Nagao S, Wallace DP, et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 2003; 63: 1983-94. (Pubitemid 36605809)
26. Hanaoka K, Guggino WB. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 2000; 11: 1179-87. (Pubitemid 30416213)
27. Sirac C, Bridoux F, Essig M, Devuyst O, Touchard G, Cogné M. Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Contrib Nephrol 2011; 169: 247-61.